Protein S blocks the extrinsic apoptotic cascade in tissue plasminogen activator/N-methyl D-aspartate-treated neurons via Tyro3-Akt-FKHRL1 signaling pathway

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Guo, Huang ^a   Barrett, Theresa M ^a   Zhong, Zhihui ^a   Fernndez, José A ^b   Griffin, John H ^b   Freeman, Robert S ^a   Zlokovic, Berislav V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; FAS LIGAND; N METHYL DEXTRO ASPARTIC ACID; PROTEIN KINASE B; PROTEIN S; TISSUE PLASMINOGEN ACTIVATOR; TYROSINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL KILLING; MOUSE; NERVE CELL; NONHUMAN; PROTEIN PHOSPHORYLATION;

ANIMALIA;

EID: 79551540928     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-13     Document Type: Article

References (65)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, N Engl J Med 1995 333 1581 1587 10.1056/NEJM199512143332401 7477192
2. National US estimates of recombinant tissue plasminogen activator use: ICD-9 codes substantially underestimate. D Kleindorfer CJ Lindsell L Brass W Koroshetz JP Broderick (Pubitemid 351619542)
3. Thrombolytic Therapy for Acute Ischemic Stroke beyond Three Hours. CR Carpenter SM Keim WK Milne WJ Meurer WG Barsan, J Emerg Med 2010 40 82 92 10.1016/j.jemermed.2010.05.009 20576390
4. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. M Yepes M Sandkvist EG Moore TH Bugge DK Strickland DA Lawrence, J Clin Invest 2003 112 1533 1540 14617754 (Pubitemid 38056279)
5. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. T Cheng AL Petraglia Z Li M Thiyagarajan Z Zhong Z Wu D Liu SB Maggirwar R Deane JA Fernandez B LaRue JH Griffin M Chopp BV Zlokovic, Nat Med 2006 12 1278 1285 10.1038/nm1498 17072311 (Pubitemid 44706930)
6. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. M Yepes BD Roussel C Ali D Vivien, Trends Neurosci 2009 32 48 55 10.1016/j.tins.2008.09.006 18963068
7. Intravenous administration of a GPIIb/IIIa receptor antagonist extends the therapeutic window of intra-arterial tenecteplase-tissue plasminogen activator in a rat stroke model. L Zhang ZG Zhang C Zhang RL Zhang M Chopp, Stroke 2004 35 2890 2895 10.1161/01.STR.0000147963.68238.da 15514182 (Pubitemid 39565190)
8. Analysis of combined treatment of embolic stroke in rat with r-tPA and a GPIIb/IIIa inhibitor. G Ding Q Jiang L Zhang ZG Zhang L Li RA Knight JR Ewing Y Wang M Chopp, J Cereb Blood Flow Metab 2005 25 87 97 10.1038/sj.jcbfm.9600010 15678115 (Pubitemid 40096900)
9. Thrombolysis with plasmin: implications for stroke treatment. VJ Marder R Jahan T Gruber A Goyal V Arora, Stroke 2010 41 45 49 10.1161/STROKEAHA.110. 595157 20876504
10. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, Stroke 1997 28 2109 2118 9368550
11. Alteplase for ischaemic stroke - much sooner is much better. JL Saver SR Levine, Lancet 2010 375 1667 1668 10.1016/S0140-6736(10)60634-4 20472152
12. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. YF Wang SE Tsirka S Strickland PE Stieg SG Soriano SA Lipton, Nat Med 1998 4 228 231 10.1038/nm0298-228 9461198 (Pubitemid 28138083)
13. Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster models. N Nagai I Vanlinthout D Collen, Circulation 1999 100 2541 2546 10604893 (Pubitemid 30005119)
14. Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C. D Liu T Cheng H Guo JA Fernandez JH Griffin X Song BV Zlokovic, Nat Med 2004 10 1379 1383 10.1038/nm1122 15516929 (Pubitemid 40022721)
15. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. O Nicole F Docagne C Ali I Margaill P Carmeliet ET MacKenzie D Vivien A Buisson, Nat Med 2001 7 59 64 10.1038/83358 11135617
16. NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity. A Baron A Montagne F Casse S Launay E Maubert C Ali D Vivien, Cell Death Differ 2009 17 860 71 10.1038/cdd.2009.172 19911010
17. Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. K Benchenane H Castel M Boulouard R Bluthe M Fernandez-Monreal BD Roussel JP Lopez-Atalaya S Butt-Gueulle V Agin E Maubert R Dantzer O Touzani F Dauphin D Vivien C Ali, J Cell Sci 2007 120 578 585 10.1242/jcs.03354 17244650 (Pubitemid 46437892)
18. Tissue plasminogen activator and NMDA receptor cleavage. T Matys S Strickland, Nat Med 2003 9 371 372 author reply 372-373 10.1038/nm0403-371 12669038
19. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. M Arundine M Tymianski, Cell Mol Life Sci 2004 61 657 668 10.1007/s00018-003-3319-x 15052409 (Pubitemid 38446410)
20. Glutamate receptors, neurotoxicity and neurodegeneration. A Lau M Tymianski, Pflugers Arch 2010 460 525 542 10.1007/s00424-010-0809-1 20229265
21. The tale of protein S and C4b-binding protein, a story of affection. B Dahlback, Thromb Haemost 2007 98 90 96 17597997 (Pubitemid 47074183)
22. Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells. O Benzakour C Formstone S Rahman C Kanthou U Dennehy MF Scully VV Kakkar DN Cooper, Biochem J 1995 308 Pt 2 481 485 7772030
23. Species-specific anticoagulant and mitogenic activities of murine protein S. JA Fernandez MJ Heeb X Xu I Singh BV Zlokovic JH Griffin, Haematologica 2009 94 1721 1731 10.3324/haematol.2009.009233 19815836
24. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. GP Gasic CP Arenas TB Gasic GJ Gasic, Proc Natl Acad Sci USA 1992 89 2317 2320 10.1073/pnas.89.6.2317 1532256
25. Protein S confers neuronal protection during ischemic/hypoxic injury in mice. D Liu H Guo JH Griffin JA Fernandez BV Zlokovic, Circulation 2003 107 1791 1796 10.1161/01.CIR.0000058460.34453.5A 12665496 (Pubitemid 36418361)
26. Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor. D Zhu Y Wang I Singh RD Bell R Deane Z Zhong A Sagare EA Winkler BV Zlokovic, Blood 2010 115 4963 4972 10.1182/blood-2010-01-262386 20348395
27. Protein S protects neurons from excitotoxic injury by activating the TAM receptor Tyro-PI3K-Akt pathway through its SHBG-like region. Z Zhong Y Wang H Guo A Sagare RD Bell JA Fernandez TM Barrett JD Griffin RS Freeman BV Zlokovic, J Neurosci 2010 30 15521 15534 10.1523/JNEUROSCI.4437-10.2010 21084607
28. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. L del Peso M Gonzalez-Garcia C Page R Herrera G Nunez, Science 1997 278 687 689 10.1126/science.278.5338.687 9381178 (Pubitemid 27464966)
29. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. SR Datta H Dudek X Tao S Masters H Fu Y Gotoh ME Greenberg, Cell 1997 91 231 241 10.1016/S0092-8674(00)80405-5 9346240 (Pubitemid 27456390)
30. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. LD Mayo DB Donner, Proc Natl Acad Sci USA 2001 98 11598 11603 10.1073/pnas.181181198 11504915 (Pubitemid 32928774)
31. Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis. TM Gottlieb JF Leal R Seger Y Taya M Oren, Oncogene 2002 21 1299 1303 10.1038/sj.onc.1205181 11850850 (Pubitemid 34185247)
32. Expression of the receptor protein-tyrosine kinases Tyro-3, Axl, and mer in the developing rat central nervous system. AL Prieto JL Weber C Lai, J Comp Neurol 2000 425 295 314 10.1002/1096-9861(20000918)425:2<295::AID-CNE11>3. 0.CO;2-G 10954847 (Pubitemid 30660454)
33. Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. MO Hall MS Obin MJ Heeb BL Burgess TA Abrams, Exp Eye Res 2005 81 581 591 10.1016/j.exer.2005.03.017 15949798 (Pubitemid 41532003)
34. Auto-oxidation and oligomerization of protein S on the apoptotic cell surface is required for Mer tyrosine kinase-mediated phagocytosis of apoptotic cells. H Uehara E Shacter, J Immunol 2008 180 2522 2530 18250462
35. TAM receptor function in the retinal pigment epithelium. D Prasad CV Rothlin P Burrola T Burstyn-Cohen Q Lu P Garcia de Frutos G Lemke, Mol Cell Neurosci 2006 33 96 108 10.1016/j.mcn.2006.06.011 16901715 (Pubitemid 44291594)
36. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Q Lu G Lemke, Science 2001 293 306 311 10.1126/science.1061663 11452127 (Pubitemid 32694748)
37. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. T Burstyn-Cohen MJ Heeb G Lemke, J Clin Invest 2009 119 2942 2953 10.1172/JCI39325 19729839
38. Generation and phenotypic analysis of protein S-deficient mice. F Saller AC Brisset SN Tchaikovski M Azevedo R Chrast JA Fernandez M Schapira TM Hackeng JH Griffin A Angelillo-Scherrer, Blood 2009 114 2307 2314 10.1182/blood-2009-03- 209031 19567881
39. Chamaecypanone C, a novel skeleton microtubule inhibitor, with anticancer activity by trigger caspase 8-Fas/FasL dependent apoptotic pathway in human cancer cells. CC Hsieh YH Kuo CC Kuo LT Chen CH Cheung TY Chao CH Lin WY Pan CY Chang SC Chien TW Chen CC Lung JY Chang, Biochem Pharmacol 2010 79 1261 1271 10.1016/j.bcp.2009.12.017 20034474
40. Activation of phosphatidylinositol 3-kinase/protein kinase B pathway by a vanadyl compound mediates its neuroprotective effect in mouse brain ischemia. N Shioda T Ishigami F Han S Moriguchi M Shibuya Y Iwabuchi K Fukunaga, Neuroscience 2007 148 221 229 10.1016/j.neuroscience.2007.05.040 17629407 (Pubitemid 47211622)
41. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. H Zhao T Shimohata JQ Wang G Sun DW Schaal RM Sapolsky GK Steinberg, J Neurosci 2005 25 9794 9806 10.1523/JNEUROSCI.3163-05.2005 16237183 (Pubitemid 41510919)
42. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. A Brunet A Bonni MJ Zigmond MZ Lin P Juo LS Hu MJ Anderson KC Arden J Blenis ME Greenberg, Cell 1999 96 857 868 10.1016/S0092-8674(00) 80595-4 10102273 (Pubitemid 29165088)
43. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. D Accili KC Arden, Cell 2004 117 421 426 10.1016/S0092-8674(04) 00452-0 15137936 (Pubitemid 38610228)
44. FOXO transcription factors as regulators of immune homeostasis: molecules to die for? KU Birkenkamp PJ Coffer, J Immunol 2003 171 1623 1629 12902457 (Pubitemid 36966442)
45. Direct control of the Forkhead transcription factor AFX by protein kinase B. GJ Kops ND de Ruiter AM De Vries-Smits DR Powell JL Bos BM Burgering, Nature 1999 398 630 634 10.1038/19328 10217147 (Pubitemid 29183692)
46. Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. RJ Crowder RS Freeman, J Neurosci 1998 18 2933 2943 9526010 (Pubitemid 28163223)
47. Adenovirus-mediated gene transfer of FKHRL1 triple mutant efficiently induces apoptosis in melanoma cells. JG Gomez-Gutierrez V Souza HY Hao R Montes de Oca-Luna YB Dong HS Zhou KM McMasters, Cancer Biol Ther 2006 5 875 883 10.4161/cbt.5.7.2911 16861905 (Pubitemid 44775149)
48. Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia-derived cell lines via the production of tumor necrosis factor-related apoptosis-inducing ligand. S Kikuchi T Nagai M Kunitama K Kirito K Ozawa N Komatsu, Cancer Sci 2007 98 1949 1958 10.1111/j.1349-7006.2007.00623.x 17900262 (Pubitemid 350002202)
49. Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3. H Guo D Liu H Gelbard T Cheng R Insalaco JA Fernandez JH Griffin BV Zlokovic, Neuron 2004 41 563 572 10.1016/S0896-6273(04)00019-4 14980205 (Pubitemid 38253068)
50. BID mediates neuronal cell death after oxygen/glucose deprivation and focal cerebral ischemia. N Plesnila S Zinkel DA Le S Amin-Hanjani Y Wu J Qiu A Chiarugi SS Thomas DS Kohane SJ Korsmeyer MA Moskowitz, Proc Natl Acad Sci USA 2001 98 15318 15323 10.1073/pnas.261323298 11742085 (Pubitemid 34014012)
51. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Z Zhang L Zhang M Yepes Q Jiang Q Li P Arniego TA Coleman DA Lawrence M Chopp, Circulation 2002 106 740 745 12163437 (Pubitemid 34851936)
52. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity. JP Lopez-Atalaya BD Roussel D Levrat J Parcq O Nicole Y Hommet K Benchenane H Castel J Leprince D To Van R Bureau S Rault H Vaudry KU Petersen JS Santos C Ali D Vivien, J Cereb Blood Flow Metab 2008 28 1212 1221 10.1038/jcbfm.2008.14 18334994 (Pubitemid 351733345)
53. Ethanol-withdrawal seizures are controlled by tissue plasminogen activator via modulation of NR2B-containing NMDA receptors. R Pawlak JP Melchor T Matys AE Skrzypiec S Strickland, Proc Natl Acad Sci USA 2005 102 443 448 10.1073/pnas.0406454102 15630096 (Pubitemid 40116786)
54. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors. AM Martin C Kuhlmann S Trossbach S Jaeger E Waldron A Roebroek HJ Luhmann A Laatsch S Weggen V Lessmann CU Pietrzik, J Biol Chem 2008 283 12004 12013 10.1074/jbc.M707607200 18321860
55. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. X Wang SR Lee K Arai K Tsuji GW Rebeck EH Lo, Nat Med 2003 9 1313 1317 10.1038/nm926 12960961 (Pubitemid 37279856)
56. Tissue-type plasminogen activator-mediated shedding of astrocytic low-density lipoprotein receptor-related protein increases the permeability of the neurovascular unit. R Polavarapu MC Gongora H Yi S Ranganthan DA Lawrence D Strickland M Yepes, Blood 2007 109 3270 3278 10.1182/blood-2006-08-043125 17170123 (Pubitemid 46572512)
57. Neurodegeneration and the neurovascular unit. BV Zlokovic, Nat Med 2010 16 1370 1371 10.1038/nm1210-1370 21135839
58. Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. RD Bell EA Winkler AP Sagare I Singh B LaRue R Deane BV Zlokovic, Neuron 2010 68 409 427 10.1016/j.neuron.2010.09.043 21040844
59. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. EA Winkler RD Bell BV Zlokovic, Mol Neurodegener 2010 5 32 10.1186/1750-1326-5-32 20738866
60. Collateral neuronal apoptosis in CNS gray matter during an oligodendrocyte-directed CD8(+) T cell attack. K Gobel N Melzer AM Herrmann MK Schuhmann S Bittner CW Ip T Hunig SG Meuth H Wiendl, Glia 2010 58 469 480 19780193
61. Intracellular mechanisms of cyclosporin A-induced tubular cell apoptosis. P Justo C Lorz A Sanz J Egido A Ortiz, J Am Soc Nephrol 2003 14 3072 3080 10.1097/01.ASN.0000099383.57934.0E 14638906 (Pubitemid 37509285)
62. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Q Lu M Gore Q Zhang T Camenisch S Boast F Casagranda C Lai MK Skinner R Klein GK Matsushima HS Earp SP Goff G Lemke, Nature 1999 398 723 728 10.1038/19554 10227296 (Pubitemid 29197652)
63. TAM receptors are pleiotropic inhibitors of the innate immune response. CV Rothlin S Ghosh EI Zuniga MB Oldstone G Lemke, Cell 2007 131 1124 1136 10.1016/j.cell.2007.10.034 18083102 (Pubitemid 350235020)
64. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. GJ Brewer JR Torricelli EK Evege PJ Price, J Neurosci Res 1993 35 567 576 10.1002/jnr.490350513 8377226 (Pubitemid 23215708)
65. Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity. H Guo I Singh Y Wang R Deane T Barrett JA Fernandez N Chow JH Griffin BV Zlokovic, Eur J Neurosci 2009 29 1119 1130 10.1111/j.1460-9568.2009.06664.x 19302148